We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.33%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$152B
AUM Growth
+$4.77B
Cap. Flow
+$2.89B
Cap. Flow %
1.9%
Top 10 Hldgs %
26.78%
Holding
4,133
New
185
Increased
1,882
Reduced
1,701
Closed
184

Sector Composition

Rank Sector Weight
1 Technology 17.11%
2 Financials 8.61%
3 Healthcare 7.69%
4 Industrials 6.49%
5 Consumer Discretionary 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLF icon
76
State Street Financial Select Sector SPDR ETF
XLF
$58.2B
$336M 0.22%
8,173,790
+1,138,832
+16% +$46.9M
SPGI icon
77
S&P Global
SPGI
$120B
$336M 0.22%
752,276
-5,120
-0.7% -$2.2M
DHR icon
78
Danaher
DHR
$144B
$335M 0.22%
1,339,544
-3,716
-0.3% -$939K
PM icon
79
Philip Morris
PM
$295B
$334M 0.22%
3,296,626
+1,127,286
+52% +$110M
AMGN icon
80
Amgen
AMGN
$222B
$333M 0.22%
1,065,005
-14,531
-1% -$4.27M
ABT icon
81
Abbott
ABT
$187B
$328M 0.22%
3,151,958
-1,951
-0.1% -$207K
BAC icon
82
Bank of America
BAC
$442B
$322M 0.21%
8,087,594
-1,341,895
-14% -$51.4M
FISV
83
Fiserv Inc
FISV
$27.9B
$322M 0.21%
2,157,827
+20,591
+1% +$3.12M
MCD icon
84
McDonald's
MCD
$195B
$320M 0.21%
1,255,943
+18,476
+1% +$4.9M
TJX icon
85
TJX Companies
TJX
$178B
$314M 0.21%
2,854,674
-42,859
-1% -$4.32M
ICE icon
86
Intercontinental Exchange
ICE
$84.4B
$312M 0.21%
2,282,461
+29,293
+1% +$3.94M
ACN icon
87
Accenture
ACN
$108B
$311M 0.2%
1,024,206
-87,270
-8% -$26.7M
XLY icon
88
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.2B
$310M 0.2%
3,396,222
+22,962
+0.7% +$2.04M
TXN icon
89
Texas Instruments
TXN
$261B
$307M 0.2%
1,578,823
+19,511
+1% +$3.6M
TMO icon
90
Thermo Fisher Scientific
TMO
$220B
$299M 0.2%
540,041
+26,475
+5% +$15.2M
JCI icon
91
Johnson Controls International
JCI
$92.2B
$298M 0.2%
4,485,742
+292,044
+7% +$19.7M
RTX icon
92
RTX Corp
RTX
$301B
$297M 0.19%
2,955,282
-160,242
-5% -$16.6M
ADBE icon
93
Adobe
ADBE
$105B
$289M 0.19%
519,584
-968
-0.2% -$469K
SDY icon
94
State Street SPDR S&P Dividend ETF
SDY
$23.9B
$287M 0.19%
2,256,492
-45,004
-2% -$5.8M
BBY icon
95
Best Buy
BBY
$17.3B
$285M 0.19%
3,377,763
+490,801
+17% +$39M
TSM icon
96
TSMC
TSM
$2.18T
$279M 0.18%
1,604,043
+183,215
+13% +$27.8M
INTU icon
97
Intuit
INTU
$89B
$272M 0.18%
413,993
-41,888
-9% -$26M
VPL icon
98
Vanguard FTSE Pacific ETF
VPL
$8.43B
$266M 0.17%
3,589,355
-152,893
-4% -$11.3M
LIN icon
99
Linde
LIN
$226B
$264M 0.17%
601,785
+21,809
+4% +$9.6M
NXPI icon
100
NXP Semiconductors
NXPI
$60.4B
$262M 0.17%
972,916
+9,313
+1% +$2.4M

Similar funds

Raymond James & Associates's Q2 2024 Portfolio in Review

As of Q2 2024, Raymond James & Associates held 4,133 positions worth $152B, up 3.2% from $148B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Raymond James & Associates's Q2 2024 filing shows 185 new, 1,882 increased, 1,701 reduced and 184 closed positions. Its largest new stake was Solventum: 321,226 shares worth $17M. The largest sale was State Street Health Care Select Sector SPDR ETF, an estimated $157M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Financials and Healthcare.

  • Raymond James & Associates's largest Q2 2024 buy was Solventum: 321,226 shares worth $17M.
  • Raymond James & Associates added most to iShares Core US Aggregate Bond ETF in Q2 2024, an estimated $255M increase.
  • Raymond James & Associates's biggest Q2 2024 reduction was State Street Health Care Select Sector SPDR ETF, cutting an estimated $157M.
  • Raymond James & Associates fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $110M.
  • Raymond James & Associates's ten largest holdings make up 27% of its $152B portfolio in Q2 2024.
  • Raymond James & Associates opened 185 new positions and closed 184 in Q2 2024.
  • Raymond James & Associates's portfolio value rose 3.2% quarter-over-quarter to $152B.

Based on Raymond James & Associates's 13F filing for Q2 2024, filed 19 Jul 2024.